A year into FDA’s comprehensive 510(k) reform plan, at least one thing is apparent: FDA is setting a new personal best, releasing scores of new guidance documents, standard operating procedures, pilot programs and other initiatives at a breakneck pace.
But what it will all mean for the long-term functioning of the heavily used device review path remains to be...